Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

…, R Peluso, S Iervolino, A Russolillo… - Annals of the …, 2014 - ard.bmj.com
Objectives To evaluate prospectively the effect of weight loss on the achievement of minimal
disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting …

[HTML][HTML] Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease

MND Di Minno, A Russolillo, R Lupoli… - World journal of …, 2012 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) has been recognized as a major health burden. It
is the most important cause of chronic liver disease and a major independent cardiovascular …

Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis

…, S Iervolino, R Lupoli, A Russolillo… - Arthritis care & …, 2013 - Wiley Online Library
Objective We prospectively evaluated whether obesity impacts achievement of minimal
disease activity (MDA) in subjects with psoriatic arthritis (PsA). Methods Among PsA subjects …

Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management

A Russolillo, S Iervolino, R Peluso, R Lupoli… - …, 2013 - academic.oup.com
PsA is an axial and/or peripheral inflammatory arthritis associated with psoriasis, included in
the group of spondylarthritides. It has been suggested that PsA could be a systemic disease…

Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis

…, S Iervolino, R Lupoli, A Russolillo… - … in thrombosis and …, 2012 - thieme-connect.com
In addition to a high prevalence of the metabolic syndrome and a significant under-diagnosis
of vascular risk factors (VRFs), the effect of chronic inflammation also represents the …

Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers

…, R Peluso, M Lofrano, A Russolillo… - The Journal of …, 2012 - jrheum.org
Objective. To identify predictors of early minimal disease activity in patients with psoriatic
arthritis (PsA) receiving tumor necrosis factor-α (TNF-α) antagonists. Methods. In total 146 …

Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers

…, S Iervolino, R Peluso, A Russolillo… - The Journal of …, 2012 - jrheum.org
Objective. Little is known about tumor necrosis factor-α (TNF-α) blockers, disease activity,
and liver steatosis (hepatic steatosis; HS) in subjects with psoriatic arthritis (PsA). We …

Antithrombin levels and the risk of a first episode of venous thromboembolism. A case-control study

…, F Dentali, F Veglia, A Russolillo… - Thrombosis and …, 2013 - thieme-connect.com
Although present in< 10% of patients with venous thromboembolism (VTE)(1), deficiencies
of antithrombin (AT), protein C and protein S, have been recognised as major thrombophilic …

Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update

MND Di Minno, R Lupoli, NM Palmieri, A Russolillo… - Thrombosis research, 2012 - Elsevier
In 2004 an editorial article on the so-called “aspirin resistance” and diabetic angiopathy as
related to platelet turnover was published by one of us. An update of this issue is now …

[HTML][HTML] Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study

…, R Peluso, S Iervolino, R Lupoli, A Russolillo… - Arthritis research & …, 2012 - Springer
Introduction We prospectively evaluated whether hepatic steatosis (HS) and the presence of
carotid plaques (CPs) impacts on achieving minimal disease activity (MDA) in psoriatic …